| Literature DB >> 26774035 |
Angela Di Capua1, Claudia Sticozzi2, Simone Brogi1, Margherita Brindisi1, Andrea Cappelli1, Lidia Sautebin3, Antonietta Rossi3, Simona Pace3, Carla Ghelardini4, Lorenzo Di Cesare Mannelli4, Giuseppe Valacchi5, Gianluca Giorgi1, Antonio Giordani6, Giovanna Poce7, Mariangela Biava7, Maurizio Anzini8.
Abstract
A series of substituted 1,5-diarylpyrrole-3-alkoxyethyl ethers were previously synthesized and the potential anti-inflammatory and antinociceptive activities of these compounds were evaluated in vivo. The compounds displayed a very good activity against both carrageenan-induced hyperalgesia and oedema in the rat paw test. Therefore, in a very preliminary test, compounds (8a,b) showed antiproliferative activity in the HaCaT (aneuploid immortal keratinocyte from adult human skin) cell models. On these basis, our research continued with the synthesis of fluorinated derivatives (8c,d, 9b-d, and 10b-d) with the aim of improving the pharmacokinetic profile of the previous active compounds. Substitution of a hydrogen atom by a fluorine atom may change the conformational preferences of the molecules due to stereoelectronic effects and also fluorine atom may be able to exert the metabolic obstruction reducing the "first-pass effect". Compound 10b exhibited a prominent in vivo anti-inflammatory and antinociceptive activities, in addition its antiproliferative power in an in vitro model of human skin cancer is herein described.Entities:
Keywords: 1,5-diarylpyrrole derivatives; Anti-inflammatory agents; Antinociceptive agents; Antiproliferative activity; COX-2 inhibitors; Molecular modelling
Mesh:
Substances:
Year: 2015 PMID: 26774035 DOI: 10.1016/j.ejmech.2015.12.044
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514